Antibodies

26 Jun 2020 Department of Defense Awards Ology Bioservices Contract to Advance Anti-Botulinum Neurotoxin Monoclonal Antibodies
26 Jun 2020 Philogen Received Clinical Trial Authorisation With Nidlegy in Nonmelanoma Skin Cancer
26 Jun 2020 Tizona Initiates Clinical Development of TTX-080 in Advanced Cancers
25 Jun 2020 FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) that is Not Curable by Surgery or Radiation
24 Jun 2020 Grid Therapeutics Announces Enrollment of First Patient in Phase 1 Study of GT103 in Refractory NSCLC Patients
24 Jun 2020 Alpine Immune Sciences Announces First Patient Dosed in NEON-1 Phase 1 Trial of ALPN-202 in Patients with Advanced Malignancies
24 Jun 2020 Alexion Announces Phase 3 Study of Weekly Subcutaneous ULTOMIRIS® (ravulizumab-cwvz) Met Primary Endpoint
24 Jun 2020 Aduro Biotech Announces First Patient Dosed in Phase 1 Study of BION-1301 in IgA Nephropathy
23 Jun 2020 Amunix to Present Preclinical Data on HER2- and EGFR-Targeted T Cell Engagers at AACR Virtual Annual Meeting II
23 Jun 2020 Teos Therapeutics Presents Preclinical Data for its Anti-TIGIT antibody, EOS-448, at the AACR II Virtual Annual Meeting 2020
23 Jun 2020 Jounce Therapeutics Presents First Preclinical Data on Anti-CCR8 Antibody JTX-1811 and Vopratelimab Translational Data at The American Association for Cancer Research Virtual Annual Meeting
23 Jun 2020 HiFiBiO Therapeutics Presents Three Novel Immuno-Oncology Programs at 2020 AACR Virtual Annual Meeting II
23 Jun 2020 F-star Therapeutics Presents Data on FS222 at 2020 AACR Annual Meeting
23 Jun 2020 BioInvent enrolls first patient in Phase I/IIa trial of BI-1206 in combination with KEYTRUDA[®] for the treatment of patients with solid tumors
23 Jun 2020 BioInvent presents proof-of-concept data for two TNFR2-targeting antibodies
23 Jun 2020 Affimed Announces Presentation of Data on Genentech’s RO7297089 and AFM24, Both Innate Cell Engagers Developed from Affimed’s ROCK® Platform, at AACR Virtual Annual Meeting II
23 Jun 2020 Heat Biologics Announces First Patient Treated in First-in-Human Clinical Trial of PTX-35
23 Jun 2020 European Medicines Agency Validates Application for BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
22 Jun 2020 RGENIX Presents Results from Preclinical Safety and Efficacy Studies of RGX-019 at the 2020 AACR Annual Meeting
22 Jun 2020 EpimAb Biotherapeutics Presents Preclinical Data Characterizing EMB-01 at AACR Virtual Annual Meeting II
22 Jun 2020 Xencor Presents Data from Four Preclinical XmAb® 2+1 Bispecific Antibody and Cytokine Programs at AACR Virtual Annual Meeting II
22 Jun 2020 ImmunoGen Presents Preclinical Data on IMGN151 at Virtual AACR Annual Meeting
20 Jun 2020 Innovent Announces the NMPA Granted Marketing Approval for BYVASDA® (Bevacizumab Biosimilar) in China
20 Jun 2020 NMPA Accepts Bio-Thera Solutions’ Biologics License Application (BLA) for BAT1706, A Proposed Biosimilar to Avastin®
19 Jun 2020 Genentech’s IPATential150 Study Evaluating Ipatasertib in Combination With Abiraterone and Prednisone/Prednisolone Met One of Its Co-Primary Endpoints

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top